Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | PAN domain-containing protein | 0.0287 | 0.2758 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0711 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0125 | 0 | 0.5 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0125 | 0 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0125 | 0 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0711 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0125 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0711 | 1 | 1 |
Onchocerca volvulus | 0.064 | 0.879 | 0.879 | |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0125 | 0 | 0.5 |
Toxoplasma gondii | PAN domain-containing protein | 0.0287 | 0.2758 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0125 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0711 | 1 | 1 |
Onchocerca volvulus | 0.0711 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 25 uM | Inhibition of arachidonic acid induced platelet aggregation in rabbit platelet rich plasma, range 25-50 | ChEMBL. | 6090662 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.